These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 32867307)

  • 41. Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence.
    van Ingen J; Ferro BE; Hoefsloot W; Boeree MJ; van Soolingen D
    Expert Rev Anti Infect Ther; 2013 Oct; 11(10):1065-77. PubMed ID: 24124798
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autophagy and Host Defense in Nontuberculous Mycobacterial Infection.
    Silwal P; Kim IS; Jo EK
    Front Immunol; 2021; 12():728742. PubMed ID: 34552591
    [TBL] [Abstract][Full Text] [Related]  

  • 43.
    Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activities of Dual Combinations of Antibiotics Against Multidrug-Resistant Nontuberculous Mycobacteria Recovered from Patients with Cystic Fibrosis.
    Schwartz M; Fisher S; Story-Roller E; Lamichhane G; Parrish N
    Microb Drug Resist; 2018 Oct; 24(8):1191-1197. PubMed ID: 29368988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The
    Williams JT; Giletto M; Haiderer ER; Aleiwi B; Krieger-Burke T; Ellsworth E; Abramovitch RB
    Microbiol Spectr; 2024 Jan; 12(1):e0367723. PubMed ID: 38078724
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting MmpL3 for anti-tuberculosis drug development.
    Bolla JR
    Biochem Soc Trans; 2020 Aug; 48(4):1463-1472. PubMed ID: 32662825
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Other Nontuberculous Mycobacteria: Clinical Aspects of Lung Disease Caused by Less Common Slowly Growing Nontuberculous Mycobacteria Species.
    Yan M; Brode SK; Marras TK
    Chest; 2023 Feb; 163(2):281-291. PubMed ID: 36174743
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cutaneous nontuberculous mycobacteria infections: A retrospective case series of 78 patients from the Texas Gulf Coast region.
    Philips RC; Hoyer PE; White SM; Tinkey KT; Loeffelholz M; Andersen CR; Wilkerson MG; Gibson BR; Kelly BC
    J Am Acad Dermatol; 2019 Sep; 81(3):730-739. PubMed ID: 31002850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aggregation of Nontuberculous Mycobacteria Is Regulated by Carbon-Nitrogen Balance.
    DePas WH; Bergkessel M; Newman DK
    mBio; 2019 Aug; 10(4):. PubMed ID: 31409683
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Two-Step Real-Time PCR Method To Identify Mycobacterium tuberculosis Infections and Six Dominant Nontuberculous Mycobacterial Infections from Clinical Specimens.
    Park J; Kwak N; Chae JC; Yoon EJ; Jeong SH
    Microbiol Spectr; 2023 Aug; 11(4):e0160623. PubMed ID: 37378523
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
    Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
    Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiple Mutations in Mycobacterium tuberculosis MmpL3 Increase Resistance to MmpL3 Inhibitors.
    McNeil MB; O'Malley T; Dennison D; Shelton CD; Sunde B; Parish T
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33055263
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    Zhu R; Shang Y; Chen S; Xiao H; Ren R; Wang F; Xue Y; Li L; Li Y; Chu N; Huang H
    Microbiol Spectr; 2022 Dec; 10(6):e0137222. PubMed ID: 36250885
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Atypical mycobacteria and pulmonary involvement in infectious diseases].
    Camarena Miñana JJ; Pellicer RG
    Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 5():66-75. PubMed ID: 22305672
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    Brown-Elliott BA; Rubio A; Wallace RJ
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126964
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sudapyridine (WX-081) antibacterial activity against
    Zheng L; Wang H; Qi X; Zhang W; Wang B; Fu L; Chen X; Chen X; Lu Y
    mSphere; 2024 Feb; 9(2):e0051823. PubMed ID: 38240581
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Indole-2-Carboxamides Are Active against
    Pandya AN; Prathipati PK; Hegde P; Li W; Graham KF; Mandal S; Drescher KM; Destache CJ; Ordway D; Jackson M; North EJ
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30602519
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nontuberculous mycobacteria in respiratory infections: advances in diagnosis and identification.
    Somoskovi A; Salfinger M
    Clin Lab Med; 2014 Jun; 34(2):271-95. PubMed ID: 24856528
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug susceptibility profiles and factors associated with non-tuberculous mycobacteria species circulating among patients diagnosed with pulmonary tuberculosis in Tanzania.
    Maya TG; Komba EV; Mensah GI; Mbelele PM; Mpagama SG; Mfinanga SG; Addo KK; Kazwala RR
    PLoS One; 2022; 17(3):e0265358. PubMed ID: 35324922
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New therapeutic strategies for
    Alcaraz M; Edwards TE; Kremer L
    Expert Rev Anti Infect Ther; 2023; 21(8):813-829. PubMed ID: 37314394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.